Tian Tu Capital Co Ltd (01973.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.9x

Market Cap

HKD 1.35B

MomentumView details →

1D Return

+6.85%

YTD Return

−46.28%

RSI (14)

44.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.9x

Market Cap

HKD 1.35B

RSI (14)

44.9

MomentumView details →

1D Return

+6.85%

YTD Return

−46.28%

ProfitabilityView details →

Gross Margin

92.03%

Net Margin

18.02%

EBITDA Margin

15.07%

ROE (TTM)

2.95%

ROA (TTM)

1.54%

Asset Turnover

0.09x

GrowthView details →

Revenue YoY

+438.14%

EPS YoY

+348.55%

FCF YoY

+48.96%

Revenue CAGR 3Y

−65.64%

EPS CAGR 3Y

−29.82%

EBITDA YoY

+136.75%

EarningsView details →

EPS (Actual)

HKD 0.24

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

2.91x

Quick Ratio

2.91x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.07B

Net Income (TTM)

192.72M

Op. CF (TTM)

943.52M

Next earningsApr 6, 2027 →

Latest newsMore news →

Zhejiang Qilin Zhengwei Medical Technology Co., Ltd. (KylinWay), a hydrogen molecule anti-aging new materials company, completed a Series A financing of tens of millions of RMB, led by the Meili Linghang Fund under Tiantu Investment.2d ago

Tiantu Capital proposed an interim dividend of 0.15 RMB per share.9d ago

Similar companies

Virtus Ceredex Mid-Cap Value Equity ISMVTX Cohen & Steers Global Realty ICSSPX Boston Partners All-Cap Value Fd Insti ClassBPAIX China Financial International Investments Limited00721.HK Principal MidCap S&P 400 Index Fund;R-5PMFPX Calvert Balanced CCSGCX Find similar companies →

Latest newsMore news →

Zhejiang Qilin Zhengwei Medical Technology Co., Ltd. (KylinWay), a hydrogen molecule anti-aging new materials company, completed a Series A financing of tens of millions of RMB, led by the Meili Linghang Fund under Tiantu Investment.2d ago Tiantu Capital proposed an interim dividend of 0.15 RMB per share.9d ago Tiantu Capital reported interim results for the six months ended June 2026, with net profit of 72.235 million RMB, down 4.96% year-on-year, and revenue of 2.442 million RMB, down 82.8%.9d ago